Results showed that higher EZH2 expression was significantly associated with higher tumour size (P = .019), poorer differentiation (P = .006), higher clinical stage (P = .023) and the presence of nodal metastasis (P = .012), but not with age, gender, drink, smoke and recurrence (Table 2). Here, EZH2 is linked to neoplasm.